rs75430014
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_000159.4(GCDH):c.271+3G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000279 in 1,614,224 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000159.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GCDH | NM_000159.4 | c.271+3G>A | splice_region_variant, intron_variant | ENST00000222214.10 | NP_000150.1 | |||
GCDH | NM_013976.5 | c.271+3G>A | splice_region_variant, intron_variant | NP_039663.1 | ||||
GCDH | NR_102316.1 | n.379+3G>A | splice_region_variant, intron_variant | |||||
GCDH | NR_102317.1 | n.687+3G>A | splice_region_variant, intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GCDH | ENST00000222214.10 | c.271+3G>A | splice_region_variant, intron_variant | 1 | NM_000159.4 | ENSP00000222214.4 |
Frequencies
GnomAD3 genomes AF: 0.00157 AC: 239AN: 152214Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000358 AC: 90AN: 251398Hom.: 0 AF XY: 0.000250 AC XY: 34AN XY: 135890
GnomAD4 exome AF: 0.000133 AC: 194AN: 1461892Hom.: 0 Cov.: 33 AF XY: 0.0000976 AC XY: 71AN XY: 727248
GnomAD4 genome AF: 0.00169 AC: 257AN: 152332Hom.: 5 Cov.: 32 AF XY: 0.00183 AC XY: 136AN XY: 74492
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:2
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Jun 04, 2015 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 14, 2019 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Apr 11, 2024 | BS1 - |
Glutaric aciduria, type 1 Benign:2
Likely benign, no assertion criteria provided | clinical testing | Natera, Inc. | May 29, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
not specified Benign:1
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at